Literature DB >> 6349581

Toxicological evaluation of cyclosporin A.

B Ryffel, P Donatsch, M Madörin, B E Matter, G Rüttimann, H Schön, R Stoll, J Wilson.   

Abstract

Toxicological studies in a variety of different animal species have shown that cyclosporin A (CS-A) is a unique immunosuppressant, since it does not cause myelotoxic, teratogenic, mutagenic, or carcinogenic effects. This is undoubtedly due to the fact CS-A produces its immunosuppressive effects by a specific action on T lymphocytes rather than by a cytotoxic mechanism. The incidence of acute inflammatory lesions was also not significantly higher in treated animals than in controls. Clear-cut organ toxicity only occurred in rats and cynomolgus monkeys, where at high doses nephro- and hepatotoxicity were observed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6349581     DOI: 10.1007/bf00302721

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  33 in total

1.  Effect of cyclosporin on renin-angiotensin-aldosterone system.

Authors:  H Siegl; B Ryffel
Journal:  Lancet       Date:  1982-12-04       Impact factor: 79.321

2.  Malignant lymphoma in cyclosporin A treated allograft recipients.

Authors:  C P Bieber; B A Reitz; S W Jamieson; P E Oyer; E B Stinson
Journal:  Lancet       Date:  1980-01-05       Impact factor: 79.321

Review 3.  Cyclosporin A.

Authors:  P J Morris
Journal:  Transplantation       Date:  1981-11       Impact factor: 4.939

4.  Genotoxicity evaluation of cyclosporin A, a new immunosuppressive agent.

Authors:  B E Matter; P Donatsch; R R Racine; B Schmid; W Suter
Journal:  Mutat Res       Date:  1982-10       Impact factor: 2.433

5.  Nephrotoxicity of cyclosporin A in liver and kidney transplant patients.

Authors:  G B Klintmalm; S Iwatsuki; T E Starzl
Journal:  Lancet       Date:  1981-02-28       Impact factor: 79.321

6.  A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

Authors:  P Donatsch; E Abisch; M Homberger; R Traber; M Trapp; R Voges
Journal:  J Immunoassay       Date:  1981

Review 7.  Nephrotoxic acute renal failure due to common drugs.

Authors:  G A Porter; W M Bennett
Journal:  Am J Physiol       Date:  1981-07

8.  Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury.

Authors:  H Shulman; G Striker; H J Deeg; M Kennedy; R Storb; E D Thomas
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245

9.  Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.

Authors:  D Bunjes; C Hardt; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1981-08       Impact factor: 5.532

10.  Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours.

Authors:  S A Eccles; S E Heckford; P Alexander
Journal:  Br J Cancer       Date:  1980-08       Impact factor: 7.640

View more
  21 in total

1.  Pharmacokinetics and chronic toxicity of cyclosporine A in genetic hydroxylation-deficient dark Agouti rats.

Authors:  S Koehn; F J Frey; R F Speck; T Zeugin; T Schaffner; A Zimmermann; B M Frey
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

2.  The effects of co-dergocrine on cyclosporin A pharmacokinetics and pharmacodynamics.

Authors:  D A Heinrichs; R Martell; C R Stiller; D Freeman; G Carruthers
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

Review 3.  Complications of cyclosporin therapy.

Authors:  B D Kahan; S M Flechner; M I Lorber; C Jensen; D Golden; C T Van Buren
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

4.  Co-administration of cyclosporine an alleviates thioacetamide-induced liver injury.

Authors:  Sabrina Fan; Ching-Feng Weng
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

5.  Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry.

Authors:  K Nooter; R Oostrum; R Jonker; H van Dekken; W Stokdijk; G van den Engh
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats.

Authors:  U Helmchen; W E Schmidt; E G Siegel; W Creutzfeldt
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

7.  Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice.

Authors:  K Kawaida; K Matsumoto; H Shimazu; T Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  Renal injury induced by long-term administration of cyclosporin A to rats.

Authors:  T Bertani; N Perico; M Abbate; C Battaglia; G Remuzzi
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

Review 9.  Acute cyclosporin overdose. A review of present clinical experience.

Authors:  F Arellano; C Monka; P F Krupp
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

10.  Importance of endogenous prostaglandins for the toxicity of cyclosporin A to rat endocrine and exocrine pancreas?

Authors:  M Rünzi; B M Peskar; J von Schönfeld; M K Müller
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.